ClinicalTrials.gov
ClinicalTrials.gov Menu

Bupivacaine Effectiveness and Safety in SABER™ Trial (BESST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01052012
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : December 22, 2011
Sponsor:
Collaborators:
Nycomed
Hospira, now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Durect

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : September 2011
  Certification/Extension First Submitted : December 20, 2011